US Stock MarketDetailed Quotes
FATE Fate Therapeutics
- 1.925
- -0.255-11.70%
Close Dec 12 16:00 ET
- 1.998
- +0.073+3.80%
Post 19:43 ET
219.25MMarket Cap-1.17P/E (TTM)
2.220High1.900Low5.63MVolume2.220Open2.180Pre Close11.22MTurnover5.70%Turnover RatioLossP/E (Static)113.89MShares8.83052wk High0.61P/B190.17MFloat Cap1.90052wk Low--Dividend TTM98.79MShs Float121.160Historical High--Div YieldTTM14.68%Amplitude1.460Historical Low1.992Avg Price1Lot Size
Fate Therapeutics Key Stats
EPS
According to the latest financial report of Fate Therapeutics, the latest earnings per share (TTM) for the company is -0.40. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Fate Therapeutics's free cash flow? The latest report shows it as -29.91M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Fate Therapeutics shows that the company's current ratio is 8.29, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Fate Therapeutics, the quick ratio is 8.04, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Fate Therapeutics? The latest ROE figure is -12.56%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Fate Therapeutics, the total asset return on investment (ROA) is -9.31%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Fate Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Fate Therapeutics, the net profit margin is -1.55K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Heat List
US
Overall
Symbol
Price
% Chg
No Data